BRCA1 and Prostate Cancer

REFERENCES

• Miki Y., Swensen J., Shattuck-Eidens D., et al. A Strong Candidate for the Breast and Ovarian Cancer Susceptibility Gene BRCA1. Science 1994; 266: 66–71
   PubMed Web of Science ®Google Scholar
• Ford D., Easton D. F., Bishop D. T., et al. Risks of Cancer in BRCA1-Mutation Carriers. Breast Cancer Linkage Consortium. Lancet 1994; 343: 692–695
   PubMed Web of Science ®Google Scholar
• Friedman L. S., Ostermeyer E. A., Szabo C. I., et al. Confirmation of BRCA1 by Analysis of Germline Mutations Linked to Breast and Ovarian Cancer in Ten Families. Nat. Genet. 1994; 8: 399–404
   PubMed Web of Science ®Google Scholar
• Easton D. F., Ford D., Bishop D. T. Breast and Ovarian Cancer Incidence in BRCA1-Mutation Carriers. The Breast Cancer Linkage Consortium. Am. J. Hum. Genet. 1995; 56: 265–271
   PubMed Web of Science ®Google Scholar
• Chapman M. S., Verma I. M. Transcriptional Activation by BRCA1. Nature 1996; 382: 678–679
   PubMedGoogle Scholar
• Monteiro A. N., August A., Hanafusa H. Evidence for a Transcription Activation Function of BRCA1 C-Terminal Region. Proc. Natl. Acad. Sci. U.S.A. 1996; 93: 13595–13599
   PubMed Web of Science ®Google Scholar
• Jensen R. A., Thompson M. E., Jetton T. L., et al. BRCA1 Is a Secreted Protein and Exhibits Properties of a Granin. Nat. Genet. 1996; 12: 303–308
   PubMed Web of Science ®Google Scholar
• Chen Y., Farmer A. A., Chen C-F., et al. BRCA1 Is a 200 kDa Nuclear Phosphoprotein That Is Expressed and Phosphorylated in a Cell Cycle-Dependent Manner. Cancer Res. 1996; 56: 3168–3172
   PubMed Web of Science ®Google Scholar
• Chen C. F., Li S., Chen Y., et al. The Nuclear Localization Sequences of the BRCA1 Protein Interact with the Importin-Alpha Subunit of the Nuclear Transport Signal Receptor. J. Biol. Chem. 1996; 271: 32863–32868
   PubMed Web of Science ®Google Scholar
• Scully R., Ganesan S., Brown M., et al. Location of BRCA1 in Human Breast and Ovarian Cell Lines. Science 1996; 272: 123–125
   PubMed Web of Science ®Google Scholar
• Thakur S., Zhang H. B., Peng Y., et al. Localization of BRCA1 and a Splice Variant Identifies the Nuclear Localization Signal. Mol. Cell. Biol. 1997; 17: 444–452
   PubMed Web of Science ®Google Scholar
• Thomas J. E., Smith M., Rubinfeld B., et al. Subcellular Localization and Analysis of Apparent 180-kDa and 220-kDa Proteins of the Breast Cancer Susceptibility Gene, BRCA1. J. Biol. Chem. 1996; 271: 28630–29635
   PubMed Web of Science ®Google Scholar
• Chen Y., Chen C. F., Riley D. J., et al. Aberrant Subcellular Localization of BRCA1 in Breast Cancer. Science 1995; 270: 789–791
   PubMed Web of Science ®Google Scholar
• Chen Y., Chen P-L., Riley D. J., et al. Nuclear Location of BRCA1 in Human Breast and Ovarian Cancer Cells. Science 1997; 272: 125–126
   Web of Science ®Google Scholar
• Wilson C. A., Payton M. N., Elliott G. S., et al. Differential Subcellular Localization, Expression, and Biological Toxicity of BRCA1 and the Splice Variant BRCA1-delta11b. Oncogene 1997; 14: 1–16
   PubMed Web of Science ®Google Scholar
• Smith T. M., Lee M. K., Szabo C. I., et al. Complete Genomic Sequence and Analysis of 117 kb of Human DNA Containing the Gene BRCA1. Genome Res. 1996; 6: 1029–1049
   PubMed Web of Science ®Google Scholar
• Saurin A. J., Borden K. L.B., Boddy M. N., et al. Does This Have a Familiar RING?. Trends Biochem. Sci. 1996; 21: 208–214
   PubMed Web of Science ®Google Scholar
• Wu L. C., Wang Z. W., Tsan J. T., et al. Identification of a RING Protein That Can Interact In Vivo with the BRCA1 Gene Product. Nat. Genet. 1996; 14: 430–440
   PubMed Web of Science ®Google Scholar
• Thai T. H., Du F., Tsan J. T., et al. Mutations in the BRCA1-Associated RING Domain (BARD1) Gene in Primary Breast, Ovarian, and Uterine Cancers. Hum. Mol. Genet. 1998; 7: 195–202
   PubMed Web of Science ®Google Scholar
• Kleiman F. E., Manley J. L. Functional Interaction of BRCA1-Associated BARD1 with Polyadenylation Factor CstF-50. Science 1999; 285: 1576–1579
   PubMed Web of Science ®Google Scholar
• Wang H., Shao N., Ding O. M., et al. BRCA1 Proteins Are Transported to the Nucleus in the Absence of Serum and Splice Variants BRCA1a, BRCA1b Are Phosphoproteins That Associate with E2F, Cyclins, and Cyclin-Dependent Kinases. Oncogene 1997; 15: 143–147
   PubMed Web of Science ®Google Scholar
• Jensen D. E., Proctor M., Marquis S. T., et al. BAP1: A Novel Ubiquitin Hydrolase Which Binds to the BRCA1 RING Finger and Enhances BRCA1-Mediated Cell Growth Suppression. Oncogene 1998; 16: 1097–1112
   PubMed Web of Science ®Google Scholar
• Koonin V. F., Altschul S. F., Bork P. BRCA1 Protein Products: Functional Motifs. Nat. Genet. 1996; 13: 266–267
   PubMed Web of Science ®Google Scholar
• Bork P., Hofmann K., Bucher P., et al. A Superfamily of Conserved Domains in DNA Damage-Responsive Cell Cycle Checkpoint Proteins. FASEB J. 1997; 11: 68–76
   PubMed Web of Science ®Google Scholar
• Somasundaram K., Zhang H., Zeng Y-X., et al. Arrest of the Cell Cycle by the Tumor Suppressor BRCA1 Requires the CDK-Inhibitor p21WAF1/CIP1. Nature 1997; 389: 187–190
   PubMed Web of Science ®Google Scholar
• Abel K. J., Xu J., Yin G-Y., et al. Mouse BRCA1: Localization, Sequence Analysis and Identification of Evolutionarily Conserved Domains. Hum. Mol. Genet. 1995; 4: 2265–2273
   PubMed Web of Science ®Google Scholar
• Hakem R., de la Pomba J. L., Sirard C., et al. The Tumor Suppressor Gene Brca1 Is Required for Embryonic Cellular Proliferation in the Mouse. Cell 1996; 85: 1009–1023
   PubMed Web of Science ®Google Scholar
• Gowen L. C., Johnson B. L., Latour A. M., et al. BRCA1 Deficiency Results in Early Embryonic Lethality Characterized by Neuroepithelial Abnormalities. Nat. Genet. 1996; 12: 191–194
   PubMed Web of Science ®Google Scholar
• Liu C. Y., Fleskin-Nikitin A., Li S., et al. Inactivation of the Mouse Brca1 Gene Leads to Failure in the Morphogenesis of the Egg Cylinder in Early Post Implantation Development. Genes Dev. 1996; 10: 1835–1843
   PubMed Web of Science ®Google Scholar
• Hakem R., de la Pompa J. L., Elia A., et al. Partial Rescue of Brca15–6 Early Embryonic Lethality by p53 or p21 Null Mutation. Nat. Genet. 1997; 16: 296–302
   Google Scholar
• Tavtigian S. V., Simard J., Rommens J., et al. The Complete BRCA2 Gene and Mutations in Chromosome 13q-Linked Kindreds. Nat. Genet. 1996; 12: 333–337
   PubMed Web of Science ®Google Scholar
• Suzuki A., de la Pompa J. L., Hakem R., et al. Brca2 Is Required for Embryonic Cellular Proliferation in the Mouse. Genes Dev. 1997; 11: 1242–1252
   PubMed Web of Science ®Google Scholar
• Ludwig T., Chapman D. L., Papaiocannou V. E., et al. Targeted Mutations of Breast Cancer Susceptibility Gene Homologs in Mice: Lethal Phenotypes of Brca1, Brca2, Brca1/lBrca2, Brca1/p53, Brca2/p53 Nullizygous Embryos. Genes Dev. 1997; 11: 1226–1241
   PubMed Web of Science ®Google Scholar
• Sharan S. K., Morimatsu M., Albrecht U., et al. Embryo Lethality and Radiation Hypersensitivity Mediated by Rad51 in Mice Lacking Brca2. Nature 1997; 386: 804–810
   PubMed Web of Science ®Google Scholar
• Lane T. F., Deng C., Elson A., et al. Expression of Brca1 Is Associated with Terminal Differentiation of Ectodermally and Mesodermally Derived Tissues in Mice. Genes Dev. 1995; 9: 2712–2722
   PubMed Web of Science ®Google Scholar
• Marquis S. T., Rajan J. V., Wynshaw-Boris A., et al. The Developmental Pattern of Brca1 Expression Implies a Role in Differentiation of the Breast and Other Tissues. Nat. Genet. 1995; 11: 17–26
   PubMed Web of Science ®Google Scholar
• Rajan J. V., Marquis S. T., Gardner H. P., et al. Developmental Expression of Brca2 Colocalizes with Brca1 and Is Associated with Proliferation and Differentiation in Multiple Tissues. Dev. Biol. 1997; 184: 385–401
   PubMed Web of Science ®Google Scholar
• Futreal P. A., Liu Q., Shattuck-Eidens D., et al. BRCA1 Mutations in Primary Breast and Ovarian Carcinomas. Science 1994; 266: 120–122
   PubMed Web of Science ®Google Scholar
• Neuhausen S. L., Marshall C. J. Loss of Heterozygosity in Familial Tumors from Three BRCA1-Linked Kindreds. Cancer Res. 1994; 54: 6069–6072
   PubMed Web of Science ®Google Scholar
• Cornelis R. S., Neuhausen S. L., Johannson O., et al. High Allele Loss Rates at 17q12-q21 in Breast and Ovarian Tumors from BRCA1-Linked Families. The Breast Cancer Linkage Consortium. Genes Chromosomes Cancer 1995; 13: 203–210
   PubMed Web of Science ®Google Scholar
• Holt J. T., Thompson M. E., Szabo C., et al. Growth Retardation and Tumor Inhibition by BRCA1. Nat. Genet. 1996; 12: 298–302
   PubMed Web of Science ®Google Scholar
• Thompson M. E., Jensen R. A., Obermiller P. S., et al. Decreased Expression of BRCA1 Accelerates Growth and Is Often Present During Sporadic Breast Cancer Progression. Nat. Genet. 1995; 9: 444–450
   PubMed Web of Science ®Google Scholar
• Vaughn J. P., Davis P. L., Jarboe M. D., et al. BRCA1 Expression Is Induced Before DNA Synthesis in Both Normal and Tumor-Derived Breast Cells. Cell Growth Differ. 1996; 7: 711–715
   PubMedGoogle Scholar
• Gudas J. M., Li T., Nguyen H., et al. Cell Cycle Regulation of BRCA1 Messenger RNA in Human Breast Epithelial Cells. Cell Growth Differ. 1996; 7: 717–723
   PubMedGoogle Scholar
• Rajan J. V., Wang M., Marquis S. T., et al. Brca2 Is Coordinately Regulated with Brca1 During Proliferation and Differentiation in Mammalian Epithelial Cells. Proc. Natl. Acad. Sci. U.S.A. 1996; 93: 3078–3083
   Google Scholar
• Scully R., Chen J., Ochs R. L., et al. Dynamic Changes of BRCA1 Subnuclear Location and Phosphorylation State Are Initiated by DNA Damage. Cell 1997; 90: 425–435
   PubMed Web of Science ®Google Scholar
• Cobrinik D. Regulatory Interactions Among E2Fs and Cell Cycle Control Proteins. Curr. Top. Microbiol. Immunol. 1996; 208: 31–61
   PubMed Web of Science ®Google Scholar
• Yarden R. I., Brody L. C. BRCA1 Interacts with Components of the Histone Deacetylase Complex. Proc. Natl. Acad. Sci. U.S.A. 1999; 96: 4983–4988
   PubMed Web of Science ®Google Scholar
• Aprelikova O. N., Fang B. S., Meissner E. G., et al. BRCA1-Associated Growth Arrest Is RB-Dependent. Proc. Natl. Acad. Sci. U.S.A. 1999; 96: 11866–11871
   PubMed Web of Science ®Google Scholar
• Larson J. S., Tonkinson J. L., Lai M. T. A BRCA1 Mutant Alters G2-M Cell Cycle Control in Human Mammary Epithelial Cells. Cancer Res. 1997; 57: 3351–3355
   PubMed Web of Science ®Google Scholar
• Scully R., Anderson S. F., Chao D. M., et al. BRCA1 Is a Component of the RNA Polymerase II Holoenzyme. Proc. Natl. Acad. Sci. U.S.A. 1997; 94: 5605–5610
   PubMed Web of Science ®Google Scholar
• Weinert T. A., Hartwell L. H. The RAD9 Gene Controls the Cell Cycle Response to DNA Damage in Saccharomyces cerevisiae. Science 1988; 241: 317–322
   PubMed Web of Science ®Google Scholar
• Vaughn J. P., Cirisano F. D., Huper G., et al. Cell Cycle Control of BRCA2. Cancer Res. 1996; 56: 4590–4594
   PubMed Web of Science ®Google Scholar
• Berwistle D., Swift S., Marston N. J., et al. Nuclear Location and Cell Cycle Regulation of the BRCA2 Protein. Cancer Res. 1997; 57: 5485–5488
   PubMed Web of Science ®Google Scholar
• Gudas J. M., Nguyen H., Li T., et al. Harmone-Dependent Regulation of BRCA1 in Human Breast Cancer Cells. Cancer Res. 1995; 55: 4561–4565
   PubMed Web of Science ®Google Scholar
• Spillman M. A., Bowcock A. M. BRCA1 and BRCA2 mRNA Levels Are Coordinately Elevated in Human Breast Cancer Cells in Response to Estrogen. Oncogene 1996; 13: 1639–1645
   PubMed Web of Science ®Google Scholar
• Marks J. R., Huper G., Vaughn J. P., et al. BRCA1 Is Not Directly Responsive to Estrogen. Oncogene 1997; 14: 115–121
   PubMed Web of Science ®Google Scholar
• Xu C. F., Brown M. A., Chambers J. A., et al. Distinct Transcription Start Sites Generate Two Forms of BRCA1 mRNA. Hum. Mol. Genet. 1995; 4: 2259–2264
   PubMed Web of Science ®Google Scholar
• Phillips K. W., Goldsworthy S. M., Bennett L. M., et al. Brca1 Is Expressed Independently of Hormonal Stimulation in the Mouse Ovary. Lab Invest. 1997; 76: 419–425
   PubMed Web of Science ®Google Scholar
• Scully R., Chen J., Plug A., et al. Association of BRCA1 with Rad51 in Mitotic and Meiotic Cells. Cell 1997; 88: 265–275
   PubMed Web of Science ®Google Scholar
• Shinohara A., Ogawa H., Ogawa T. Rad51 Protein Involved in Repair and Recombination in Saccharomyces cerevisiae Is a RecA-Like Protein. Cell 1992; 69: 457–470
   PubMed Web of Science ®Google Scholar
• Jin Y., Xu X. L., Yang M-C. W., et al. Cell Cycle-Dependent Colocalization of BARD1 and BRCA1 in Discrete Nuclear Domains. Proc. Natl. Acad. Sci. U.S.A. 1997; 94: 12075–12080
   PubMed Web of Science ®Google Scholar
• Wong A. K.C., Pero R., Ormonde P. A., et al. Rad51 Interacts with the Evolutionarily Conserved BRC Motifs in the Human Breast Cancer Susceptibility Gene brca2. J. Biol. Chem. 1997; 272: 31941–31944
   PubMed Web of Science ®Google Scholar
• Connor P., Bertwistle D., Mee P. J., et al. Tumorigenesis and a DNA Repair Defect in Mice with a Truncating Brca2 Mutation. Nat. Genet. 1997; 17: 423–430
   PubMed Web of Science ®Google Scholar
• Milner J., Ponder B., Hughes-Davies L., et al. Transcriptional Activation Functions in BRCA2 [letter]. Nature 1997; 386: 772–773
   PubMed Web of Science ®Google Scholar
• Torres-Ramos C. A., Yoder B. L., Burgers P. M., et al. Requirement of Proliferating Cell Nuclear Antigen in RAD6-Dependent Postreplicational DNA Repair. Proc. Natl. Acad. Sci. U.S.A. 1996; 93: 9676–9681
   PubMed Web of Science ®Google Scholar
• Andres J. L., Fan S., Turkel G. J., et al. Regulation of BRCA1 and BRCA2 Expression in Human Breast Cancer Cells by DNA-Damaging Agents. Oncogene 1998; 16: 2229–2241
   PubMed Web of Science ®Google Scholar
• Fan S., Twu N-F., Wang J-A., et al. Down-Regulation of BRCA1 and BRCA2 in Human Ovarian Cancer Cells Exposed to Adriamycin and UV Radiation. Int. J. Cancer 1998; 77: 600–609
   PubMed Web of Science ®Google Scholar
• Tirkkonen M., Johannson O., Agnarsson B. A., et al. Distinct Somatic Genetic Changes Associated with Tumor Progression in Carriers of BRCA1 and BRCA2 Germ-Line Mutations. Cancer Res. 1997; 57: 1222–1227
   PubMed Web of Science ®Google Scholar
• Gowen L. C., Avrutskaya A. V., Latour A. M., et al. BRCA1 Required for Transcription-Coupled Repair of Oxidative DNA Damage. Science 1998; 281: 1009–1012
   PubMed Web of Science ®Google Scholar
• Abbott D. W., Thompson M. E., Robinson-Benion C., et al. BRAC1 Expression Restores Radiation Resistance in BRCA1-Defective Cancer Cells Through Enhancement of Transcription-Coupled DNA Repair. J. Biol. Chem. 1999; 274: 18808–18813
   PubMed Web of Science ®Google Scholar
• Zhong Q., Chen C. F., Li S., et al. Association of BRCA1 with the hRad50-hMrell-p95 Complex and the DNA Damage Response. Science 1999; 285: 747–750
   PubMed Web of Science ®Google Scholar
• Cortez D., Wang Y., Qin J., Elledge S. J. Requirement of ATM-Dependent Phosphorylation of BRCA1 in the DNA Damage Response to Double-Strand Breaks. Science 1999; 286: 1162–1166
   PubMed Web of Science ®Google Scholar
• Chen J., Silver D. P., Walpita D., et al. Stable Interaction Between the Products of the BRCA1 and BRCA2 Tumor Suppressor Genes in Mitotic and Meiotic Cells. Mol. Cell 1998; 2: 317–332
   PubMed Web of Science ®Google Scholar
• Moynahan M. E., Chiu J. W., Koller B. H., Jasin M. BRCA1 Controls Homology-Directed DNA Repair. Mol. Cell 1999; 4: 511–518
   PubMed Web of Science ®Google Scholar
• Karp S. E., Tonin P. N., Begin L. R., et al. Influence of BRCA1 Mutations on Nuclear Grade and Estrogen Status of Breast Carcinoma in Ashkenazi Jewish Women. Cancer 1997; 80: 435–441
   PubMed Web of Science ®Google Scholar
• Johannsson O. T., Idvall I., Anderson C., et al. Tumor Biological Features of BRCA1-Induced Breast and Ovarian Cancer. Eur. J. Cancer 1997; 33: 362–371
   PubMed Web of Science ®Google Scholar
• Eisinger F., Stoppa D. Lyonnet, Longy M., et al. Germ Line Mutation of BRCA1 Affects the Histoprognostic Grade in Hereditary Breast Cancer. Cancer Res. 1996; 56: 471–474
   PubMed Web of Science ®Google Scholar
• Pathology of Familial Breast Cancer: Differences Between Breast Cancers in Carriers of BRCA1 and BRCA2 Mutations and Sporadic Cases. Breast Cancer Linkage Consortium. Lancet 1997; 349: 1505–1510
   PubMed Web of Science ®Google Scholar
• Van den Berg J., Johannson O., Hakansson S., et al. Allelic Loss at Chromosome 13q12-q13 Is Associated with Poor Prognosis in Familial and Sporadic Breast Cancer. Br. J. Cancer 1996; 74: 1615–1619
   PubMed Web of Science ®Google Scholar
• Wertz I. E., Hanley M. R. Diverse Molecular Provocation of Cell Death. Trends Biochem. Sci. 1996; 21: 359–364
   PubMed Web of Science ®Google Scholar
• Bergman P. J., Harris D. Radioresistance, Chemoresistance, and Apoptosis Resistance. The Past, Present, and Future. Vet. Clin. North Am. Small Anim. Pract. 1997; 27: 47–57
   PubMed Web of Science ®Google Scholar
• Levine A. J. p53, the Cellular Gatekeeper for Growth. Cell 1997; 88: 293–299
   Google Scholar
• Haupt Y., Rowan S., Shaulian E., et al. Induction of Apoptosis in HeLa Cells by Transactivation Deficient p53. Genes Dev. 1995; 9: 2170–2183
   PubMed Web of Science ®Google Scholar
• Shao N., Chai Y. L., Shyam E., et al. Induction of Apoptosis by Tumor Suppressor Protein BRCA1. Oncogene 1996; 13: 1–7
   PubMed Web of Science ®Google Scholar
• Rao V. N., Shao N., Ahmad M., et al. Antisense RNA to Putative Tumor Suppressor Gene BRCA1 Transforms Mouse Fibroblasts. Oncogene 1996; 12: 523–528
   PubMed Web of Science ®Google Scholar
• Harkin D. P., Bean J. M., Miklos D., et al. Induction of GADD45 and JNK/SAPK-Dependent Apoptosis Following Inducible Expression of BRCA1. Cell 1999; 97: 575–586
   PubMed Web of Science ®Google Scholar
• Wang X. W., Vermeulen W., Coursen J. D., et al. The XPB and XPD DNA Helicases Are Components of the p53-Mediated Apoptosis Pathway. Genes Dev. 1996; 10: 1219–1232
   PubMed Web of Science ®Google Scholar
• Ouichi T., Monteiro A. N., August A., et al. BRCA1 Regulates p53-Dependent Gene Expression. Proc. Natl. Acad. Sci. U.S.A. 1998; 95: 2302–2306
   PubMed Web of Science ®Google Scholar
• Zhang H., Somasundaram K., Peng Y., et al. BRCA1 Physically Associates with P53 and Stimulates Its Transcriptional Activity. Oncogene 1998; 16: 1713–1721
   PubMed Web of Science ®Google Scholar
• Chai Y. L., Cui J., Shao N., et al. The Second BRCT Domain of BRCA1 Proteins Interacts with p53 and Stimulates Transcription from the p21WAF1/CIP1 Promoter. Oncogene 1999; 18: 263–268
   PubMed Web of Science ®Google Scholar
• Somasundaram K., MacLachlan T. K., Burns T. F., et al. BRCA1 Signals ARF-Dependent Stabilization and Co-Activation of p53. Oncogene 1999; 18: 6605–6614
   PubMed Web of Science ®Google Scholar
• Fan S., et al. BRCA1 Inhibits Estrogen Receptor Signalling in Transfected Cells. Science 1999; 284: 1354–1356
   PubMed Web of Science ®Google Scholar
• Wang Q., Zhang H., Kajino K., Greene M. I. BRCA1 Binds c-Myc and Inhibits Its Transcriptional and Transforming Activity in Cells. Oncogene 1998; 17: 1939–1948
   PubMed Web of Science ®Google Scholar
• Yu X., Wu L. C., Bowcock A. M., et al. The C-Terminal (BRCT) Domains of BRCA1 Interact In Vivo with CtIP, a Protein Implicated in the CtBP Pathway of Transcriptional Repression. J. Biol. Chem. 1998; 273: 25388–25392
   PubMed Web of Science ®Google Scholar
• Sewalt R. G., Gunster M. J., van der Vlag J., et al. C-Terminal Binding Protein Is a Transcriptional Repres- sor That Interacts with a Specific Class of Vertebrate Polycomb Proteins. Mol. Cell. Biol. 1999; 19: 777–787
   PubMed Web of Science ®Google Scholar
• Narod S. A., Ford D., Devilee P., et al. Evaluation of Genetic Heterogeneity in 145 Breast-Ovarian Cancer Families. Breast Cancer Linkage Consortium. Am. J. Hum. Genet. 1995; 56: 254–264
   PubMed Web of Science ®Google Scholar
• Hall J. M., Lee M. K. Linkage of Early Onset Familial Breast Cancer to Chromosome 17q21. Science 1990; 250: 1684–1689
   PubMed Web of Science ®Google Scholar
• Rowell S., Newman B., Boyd J., et al. Inherited Predisposition to Breast Cancer and Ovarian Cancer. Am. J. Hum. Genet. 1994; 55: 861–865
   PubMed Web of Science ®Google Scholar
• Harris J. R., Lippman M. E., Veronesi U., et al. Breast Cancer. N. Engl. J. Med. 1992; 327: 319–328, 390–398, 473–480
   PubMed Web of Science ®Google Scholar
• Cannon-Albright L. A., Skolnick M. H. The Genetics of Familial Breast Cancer. Semin. Oncol. 1996; 23(1 suppl 2): 1–5
   Web of Science ®Google Scholar
• Greene M. H. Genetics of Breast Cancer. Mayo Clin. Proc. 1997; 72: 54–65
   PubMed Web of Science ®Google Scholar
• Narod S. A., Goldgar D., Cannon-Albright L., et al. Risk Modifiers in Carriers of BRCA1 Mutations. Int. J. Cancer 1995; 64: 1–5
   PubMedGoogle Scholar
• Streuwing J. P., Abeliovich D., Peretz T, et al. The Carrier Frequency of the BRCA1 185delAG Mutation Is Approximately 1 Percent in Ashkenazi Jewish Individuals. Nat. Genet. 1995; 11: 198–200
   PubMed Web of Science ®Google Scholar
• Roa B., Boyd A. A., Volcik K., et al. Ashkenazi Jewish Population Frequencies for Common Mutations in BRCA1 and BRCA2. Nat. Genet. 1996; 14: 188–190
   PubMedGoogle Scholar
• Streuwing J. P., Hartge P., Wacholder S., et al. The Risk of Cancer Associated with Specific Mutations of BRCA1 and BRCA2 Among Ashkenazi Jews. N. Engl. J. Med 1997; 336: 1401–1408
   PubMed Web of Science ®Google Scholar
• Ford D., Easton D. F., Peto J. Estimates of the Gene Frequency of BRCA1 and Its Contribution to Breast and Ovarian Cancer Incidence. Am. J. Hum. Genet. 1995; 57: 1457–1462
   PubMed Web of Science ®Google Scholar
• Abeliovich D., Kaduri L., Lever I., et al. The Founder Mutations 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2 Appear in 60% of Ovarian Cancer and 30% of Early-Onset Breast Cancer Patients Among Ashkenazi Women. Am. J. Hum. Genet. 1997; 60: 505–514
   PubMed Web of Science ®Google Scholar
• Gayther S. A., Warren W., Mazoyer S., et al. Germline Mutations of the BRCA1 Gene in Breast, Ovarian Cancer Families: Evidence for a Genotype/Phenotype Correlation. Nat. Genet. 1995; 11: 428–433
   PubMed Web of Science ®Google Scholar
• Runnebaum I. B., Nagarajan M., Bowman M., et al. Mutations in p53 as Potential Molecular Markers for Breast Cancer. Proc. Natl. Acad. Sci. U.S.A. 1991; 88: 10657–10661
   PubMed Web of Science ®Google Scholar
• Gayther S. A., Mangion J., Russell P., et al. Variation of Risks of Breast and Ovarian Cancer Associated with Different Germline Mutations of the BRCA2 Gene. Nat. Genet. 1997; 15: 103–105
   PubMed Web of Science ®Google Scholar
• Shaulian E., Zauberman A., Ginsberg D., et al. Identification of a Minimal Transforming Domain of p53: Negative Dominance Through Abrogation of Sequence-Specific Binding. Mol. Cell. Biol. 1992; 12: 5581–5592
   PubMed Web of Science ®Google Scholar
• Dittmer D., Pati S., Zambetti G., et al. Gain of Function Mutations in p53. Nat. Genet. 1993; 4: 42–46
   PubMed Web of Science ®Google Scholar
• Thiessen E. U. Concerning a Familial Association Between Breast Cancer and Both Prostatic and Uterine Malignancies. Cancer 1974; 34: 1102–1107
   PubMed Web of Science ®Google Scholar
• Carter B. S., Beatty T. H., Steinberg G. D., et al. Mendelian Inheritance of Familial Prostate Cancer. Proc. Natl. Acad. Sci. U.S.A. 1992; 89: 3367–3371
   PubMed Web of Science ®Google Scholar
• Whittemore A. S., Wu A. H., Kolonel L. N., et al. Family History and Prostate Cancer Risk in Black, White, and Asian Men in the United States and Canada. Am. J. Epidemiol. 1995; 141: 732–740
   PubMed Web of Science ®Google Scholar
• McCahy P. J., Harris G., Neal D. E. Breast and Prostate Cancer in Relatives of Men with Prostate Cancer. Br. J. Urol. 1996; 78: 552–556
   PubMedGoogle Scholar
• Bishop D. T., Kiemeney L. A. Family Studies and the Evidence for Genetic Susceptibility to Prostate Cancer. Semin. Cancer Biol. 1997; 8: 45–51
   PubMed Web of Science ®Google Scholar
• Tulinius H., Egilsson V., Olafsdottir G. H., et al. Risk of Prostate, Ovarian, and Endometrial Cancer among Relatives of Women with Breast Cancer. Br. Med. J. 1992; 305: 855
   PubMed Web of Science ®Google Scholar
• Anderson D. E., Badzioch M. D. Familial Breast Cancer Risks. Effects of Prostate and Other Cancers. Cancer 1993; 72: 114–119
   PubMed Web of Science ®Google Scholar
• Sellers T. A., Potter J. D., Rich S. S., et al. Familial Clustering of Breast and Prostate Cancers and Risk of Postmenopausal Breast Cancer. J. Natl. Cancer Inst. 1994; 86: 1860–1865
   PubMed Web of Science ®Google Scholar
• Jishi M. F., Itnyre J. H., Oakley-Girvan I. A., et al. Risks of Cancer in the Gilda Radner Familial Ovarian Cancer Registry. Cancer 1995; 76: 1416–1421
   PubMed Web of Science ®Google Scholar
• Langston A. A., Stanford J. L., Wicklund K. G., et al. Germ-Line BRCA1 Mutations in Selected Men with Prostate Cancer [letter]. Am. J. Hum. Genet. 1996; 58: 881–884
   PubMed Web of Science ®Google Scholar
• Arason A., Barkadottir T. B., Egilsson V. Linkage Analysis of Chromosome 17q Markers and Breast-Ovary Cancer in Icelandic Families, and Possible Relationship to Prostate Cancer. Am. J. Hum. Genet. 1993; 52: 711–717
   PubMed Web of Science ®Google Scholar
• Sigurdsson S., Thorlacius S., Tomasson J., et al. BRCA2 Mutation in Icelandic Prostate Cancer Patients. J. Mol. Med. 1997; 75: 758–761
   PubMed Web of Science ®Google Scholar
• Easton D. F., Steele L., Fields P., et al. Cancer Risks in Two Large Breast Cancer Families Linked to BRCA2 on Chromosome 13q12-13. Am. J. Hum. Genet. 1997; 61: 120–128
   PubMed Web of Science ®Google Scholar
• Thorlacius S., Olafsdottir G., Tryggvadottir L., et al. A Single BRCA2 Mutation in Male and Female Breast Cancer Families from Iceland with Varied Cancer Phenotypes. Nat. Genet. 1996; 13: 117–119
   PubMed Web of Science ®Google Scholar
• Wilkens E. P., Freije D., Xu J., et al. No Evidence for a Role of BRCA1 or BRCA2 Mutations in Ashkenazi Jewish Families with Hereditary Prostate Cancer. Prostate 1999; 39: 280–284
   PubMed Web of Science ®Google Scholar
• Nastiuk K. L., Mansukhumi M., Terry M. B., et al. Common Mutations in BRCA1 and BRCA2 Do Not Contribute to Early Prostate Cancer in Jewish Men. Prostate 1999; 40: 172–177
   PubMed Web of Science ®Google Scholar
• Hubert A., Peretz T., Manor O., et al. The Jewish Ashkenazi Founder Mutations in the BRCA1/BRCA2 Genes Are Not Found at an Increased Frequency in Ashkenazi Patients with Prostate Cancer. Am. J. Hum. Genet. 1999; 65: 921–924
   PubMed Web of Science ®Google Scholar
• Warner E., Foulkes W., Goodwin P., et al. Prevalence and Penetrance of BRCA1 and BRCA2 Gene Mutations in Unselected Ashkenazi Jewish Women with Breast Cancer. J. Natl. Cancer Inst. 1999; 91: 1241–1247
   PubMed Web of Science ®Google Scholar
• Gao X., Zacharek A., Grignon D. J., et al. Localization of Potential Tumor Suppressor Loci to a <2 Mb Region on Chromosome 17q in Human Prostate Cancer. Oncogene 1995; 11: 1241–1247
   PubMed Web of Science ®Google Scholar
• Gao X., Zacherek A., Salkowski A., et al. Loss of Heterozygosity of the BRCA1 and Other Loci on Chromosome 17q in Human Prostate Cancer. Cancer Res. 1995; 55: 1002–1005
   PubMed Web of Science ®Google Scholar
• Brothman A. R., Steele M. R., Williams B. J., et al. Loss of Chromosome 17 Loci in Prostate Cancer Detected by Polymerase Chain Reaction Quantitation of Allelic Markers. Genes Chromosomes Cancer 1995; 13: 278–284
   PubMed Web of Science ®Google Scholar
• Murakami Y. S., Brothman A. R., Leach R. J., et al. Suppression of Malignant Phenotype in a Human Prostate Cancer Cell Line by Fragments of Normal Chromosome Region 17q. Cancer Res. 1995; 55: 3389–3394
   PubMed Web of Science ®Google Scholar
• Williams B. J., Jones E., Zhu X. L., et al. Evidence for a Tumor Suppressor Gene Distal to BRCA1 in Prostate Cancer. J. Urol. 1996; 155: 720–725
   PubMed Web of Science ®Google Scholar
• Uchida T., Wang C., Sato T., et al. BRCA1 Gene Mutation and Loss of Heterozygosity on Chromosome 17q21 in Primary Prostate Cancer. Int. J. Cancer 1999; 84: 19–23
   PubMed Web of Science ®Google Scholar
• Cunningham J. M., Shan A., Wick M. J., et al. Allelic Imbalance and Microsatellite Instability in Prostate Adenocarcinoma. Cancer Res. 1996; 56: 4475–4482
   PubMed Web of Science ®Google Scholar
• Li C., Larsson C., Futreal A., et al. Identification of Two Distinct Deleted Regions on Chromosome 13 in Prostate Cancer. Oncogene 1998; 16: 481–487
   PubMed Web of Science ®Google Scholar
• Taylor J., Lymboura M., Pace P. E., et al. An Important Role for BRCA1 in Breast Cancer Progression Is Indicated by Its Loss in a Large Proportion of Non-Familial Breast Cancers. Int. J. Cancer 1998; 79: 334–342
   PubMed Web of Science ®Google Scholar
• Wilson C. A., Ramos L., Villasenor M. R., et al. Localization of Human BRCA1 and Its Loss in High-Grade, Non-Inherited Breast Carcinomas. Nat. Genet. 1999; 21: 236–240
   PubMed Web of Science ®Google Scholar
• Fan S., Wang J-A., Yuan R-Q., et al. BRCA1 as a Potential Human Prostate Tumor Suppressor: Modulation of Proliferation, Damage Responses, and Expression of Cell Regulatory Proteins. Oncogene 1998; 16: 3069–3082
   PubMed Web of Science ®Google Scholar
• Carroll A. G., Voeller H. J., Sugars L., et al. p53 Oncogene Mutations in Three Human Prostate Cancer Cell Lines. Prostate 1993; 23: 123–134
   PubMed Web of Science ®Google Scholar
• Sarkar F. H., Sakr W., Li Y. W., et al. Analysis of Retinoblastoma (RB) Gene Deletion in Human Prostatic Carcinomas. Prostate 1992; 21: 145–152
   PubMed Web of Science ®Google Scholar
• Alley M. C., Scudieco D. A., Monks A., et al. Feasibility of Drug Screening with Panels of Human Tumor Cell Lines Using a Microculture Tetrazolium Assay. Cancer Res. 1988; 48: 589–601
   PubMed Web of Science ®Google Scholar
• Bertrand R., Pommier Y. Assessment of DNA Damage in Mammalian Cells by DNA Filter Elution Methodology. Cell Growth and Apoptosis, G. P. Studzinski. Oxford University Press, OxfordU.K 1995; 97–117
   Google Scholar
• Herrmann M., Lorenz H-M., Voll R., et al. A Rapid and Simple Method for the Isolation of Apoptotic DNA Fragments. Nucleic Acids Res. 1994; 22: 5506–5507
   PubMed Web of Science ®Google Scholar
• Denmeade S. R., Lin X. S., Isaacs J. T. Role of Programmed Cell Death During the Progression and Therapy for Prostate Cancer. Prostate 1996; 28: 251–265
   PubMed Web of Science ®Google Scholar
• Garnick M. B., Fair W. R. Prostate Cancer: Emerging Concepts. Part II. Ann. Intern. Med. 1996; 125: 205–212
   PubMed Web of Science ®Google Scholar
• Sanchez-Prieto R., Lleonart M., Ramon y Cajal S. Lack of Correlation Between p53 Protein Level and Sensitivity of DNA-Damaging Agents in Keratinocytes Carrying Adenovirus E1a Mutants. Oncogene 1995; 11: 675–682
   PubMed Web of Science ®Google Scholar
• Samuelson A. V., Lowe S. W. Selective Induction of p53 and Chemosensitivity in RB-Deficient Cells by E1A Mutants Unable to Bind the RB-Related Proteins. Proc. Natl. Acad. Sci. U.S.A. 1997; 94: 12094–12099
   PubMedGoogle Scholar
• Gerritsen M. E., Williams A. J., Neish A. S., et al. CREB-Binding Protein/p300 Are Transcriptional Coactivators of p65. Proc. Natl. Acad. Sci. U.S.A. 1997; 94: 2927–2932
   PubMed Web of Science ®Google Scholar
• Hanstein B., Eckner R., DiRenzo J., et al. p300 Is a Component of an Estrogen Receptor Coactivator Complex. Proc. Natl. Acad. Sci. U.S.A. 1996; 93: 11540–11545
   PubMed Web of Science ®Google Scholar
• Smith C. L., Onate S. A., Tsai M. J., et al. CREB Binding Protein Acts Synergistically with Steroid Receptor Coactivator-1 to Enhance Steroid Dependent Transcription. Proc. Natl. Acad. Sci. U.S.A. 1996; 93: 8884–8888
   PubMed Web of Science ®Google Scholar
• Yao T. P., Ku G., Zhou N., et al. The Nuclear Hormone Receptor Coactivator SRC-1 Is a Specific Target of p300. Proc. Natl. Acad. Sci. U.S.A. 1996; 93: 10626–10631
   PubMed Web of Science ®Google Scholar
• Karp J. E., Chiarodo A., Brawley O., et al. Review. Prostate Cancer Prevention: Investigational Approaches and Opportunities. Cancer Res. 1996; 56: 5547–5556
   PubMed Web of Science ®Google Scholar